Superior outcome of upfront allogeneic hematopoietic cell transplantation versus hypomethylating agent induction in myelodysplastic syndrome

被引：2
作者：
Schroeder, Jan Christian [1 ]
Mix, Lucas [1 ]
Faustmann, Philipp [1 ]
Weller, Jan Frederic [1 ]
Fehn, Adrian [1 ]
Phely, Laurent [1 ]
Riedel, Andreas [1 ]
Vogel, Wichard [1 ]
Faul, Christoph [1 ]
Lengerke, Claudia [1 ]
Bethge, Wolfgang Andreas [1 ]
机构：
[1] Univ Hosp Tuebingen, Dept Internal Med Hematol Oncol Clin Immunol & Rhe, Tubingen, Germany
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷 / 09期
关键词：
ACUTE MYELOID-LEUKEMIA; MDS;
D O I：
10.1038/s41409-024-02365-5
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1332 / 1334
页数：3
相关论文
共 12 条
  • [1] Should Cytoreductive Treatment Be Performed Before Transplantation in Patients With High-Risk Myelodysplastic Syndrome?
    Alessandrino, Emilio Paolo
    Della Porta, Matteo Giovanni
    Pascutto, Cristiana
    Bacigalupo, Andrea
    Rambaldi, Alessandro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (21) : 2761 - 2762
  • [2] Upfront transplantation may have better outcomes than pretransplant cytoreductive therapy for treating patients with MDS-EB-1 or MDS-EB-2
    Chen, Yili
    Huang, Fen
    Xuan, Li
    Zhang, Yu
    Fan, Zhiping
    Xu, Na
    Zhao, Ke
    Xu, Jun
    Liu, Hui
    Shi, Pengcheng
    Wang, Zhixiang
    Sun, Jing
    Zheng, Weiyang
    Dai, Min
    Liu, Qifa
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (05) : 1109 - 1120
  • [3] Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel
    de Witte, Theo
    Bowen, David
    Robin, Marie
    Malcovati, Luca
    Niederwieser, Dietger
    Yakoub-Agha, Ibrahim
    Mufti, Ghulam J.
    Fenaux, Pierre
    Sanz, Guillermo
    Martino, Rodrigo
    Alessandrino, Emilio Paolo
    Onida, Francesco
    Symeonidis, Argiris
    Passweg, Jakob
    Kobbe, Guido
    Ganser, Arnold
    Platzbecker, Uwe
    Finke, Jurgen
    van Gelder, Michel
    van de Loosdrecht, Arjan A.
    Ljungman, Per
    Stauder, Reinhard
    Volin, Liisa
    Deeg, H. Joachim
    Cutler, Corey
    Saber, Wael
    Champlin, Richard
    Giralt, Sergio
    Anasetti, Claudio
    Kroeger, Nicolaus
    [J]. BLOOD, 2017, 129 (13) : 1753 - 1762
  • [4] Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
    Doehner, Hartmut
    Wei, Andrew H.
    Appelbaum, Frederick R.
    Craddock, Charles
    DiNardo, Courtney D.
    Dombret, Herve
    Ebert, Benjamin L.
    Fenaux, Pierre
    Godley, Lucy A.
    Hasserjian, Robert P.
    Larson, Richard A.
    Levine, Ross L.
    Miyazaki, Yasushi
    Niederwieser, Dietger
    Ossenkoppele, Gert
    Roellig, Christoph
    Sierra, Jorge
    Stein, Eytan M.
    Tallman, Martin S.
    Tien, Hwei-Fang
    Wang, Jianxiang
    Wierzbowska, Agnieszka
    Lowenberg, Bob
    [J]. BLOOD, 2022, 140 (12) : 1345 - 1377
  • [5] Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
    Kantarjian, Hagop M.
    Thomas, Xavier G.
    Dmoszynska, Anna
    Wierzbowska, Agnieszka
    Mazur, Grzegorz
    Mayer, Jiri
    Gau, Jyh-Pyng
    Chou, Wen-Chien
    Buckstein, Rena
    Cermak, Jaroslav
    Kuo, Ching-Yuan
    Oriol, Albert
    Ravandi, Farhad
    Faderl, Stefan
    Delaunay, Jacques
    Lysak, Daniel
    Minden, Mark
    Arthur, Christopher
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) : 2670 - 2677
  • [6] Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high-risk karyotypes
    Knipp, Sabine
    Hildebrand, Barbara
    Kuendgen, Andrea
    Giagounidis, Aristoteles
    Kobbe, Guido
    Haas, Rainer
    Aul, Carlo
    Gattermann, Norbert
    Germing, Ulrich
    [J]. CANCER, 2007, 110 (02) : 345 - 352
  • [7] Comparison Between 5-Azacytidine Treatment and Allogeneic Stem-Cell Transplantation in Elderly Patients With Advanced MDS According to Donor Availability (VidazaAllo Study)
    Kroeger, Nicolaus
    Sockel, Katja
    Wolschke, Christine
    Bethge, Wolfgang
    Schlenk, Richard F.
    Wolf, Dominik
    Stadler, Michael
    Kobbe, Guido
    Wulf, Gerald
    Bug, Gesine
    Schaefer-Eckart, Kerstin
    Scheid, Christof
    Nolte, Florian
    Kroenke, Jan
    Stelljes, Matthias
    Beelen, Dietrich
    Heinzelmann, Marion
    Haase, Detlef
    Buchner, Hannes
    Bleckert, Gabriele
    Giagounidis, Aristoteles
    Platzbecker, Uwe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (30) : 3318 - +
  • [8] Allogeneic Hematopoietic Cell Transplantation in Patients Age 60-70 Years with De Novo High-Risk Myelodysplastic Syndrome or Secondary Acute Myelogenous Leukemia: Comparison with Patients Lacking Donors Who Received Azacitidine
    Platzbecker, Uwe
    Schetelig, Johannes
    Finke, Juergen
    Trenschel, Rudolf
    Scott, Bart L.
    Kobbe, Guido
    Schaefer-Eckart, Kerstin
    Bornhaeuser, Martin
    Itzykson, Raphael
    Germing, Ulrich
    Beelen, Dietrich
    Ehninger, Gerhard
    Fenaux, Pierre
    Deeg, H. Joachim
    Ades, Lionel
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (09) : 1415 - 1421
  • [9] Upfront Allogeneic Blood Stem Cell Transplantation for Patients with High-Risk Myelodysplastic Syndrome or Secondary Acute Myeloid Leukemia Using a FLAMSA-Based High-Dose Sequential Conditioning Regimen
    Saure, Christian
    Schroeder, Thomas
    Zohren, Fabian
    Groten, Anke
    Bruns, Ingmar
    Czibere, Akos
    Galonska, Lars
    Kondakci, Mustafa
    Weigelt, Christian
    Fenk, Roland
    Germing, Ulrich
    Haas, Rainer
    Kobbe, Guido
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (03) : 466 - 472
  • [10] Comparison between Upfront Transplantation and different Pretransplant Cytoreductive Treatment Approaches in Patients with High-Risk Myelodysplastic Syndrome and Secondary Acute Myelogenous Leukemia
    Schroeder, Thomas
    Wegener, Nadija
    Lauseker, Michael
    Rautenberg, Christina
    Nachtkamp, Kathrin
    Schuler, Esther
    Kondakci, Mustafa
    Haas, Rainer
    Germing, Ulrich
    Kobbe, Guido
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (08) : 1550 - 1559
12